Search results
Jump to navigation
Jump to search
Page title matches
- In clinical [[epidemiology]] and [[evidence-based medicine]], the '''relative risk ratio''' or more simply the '''relative risk''', is a measure of the likelihood o Note that the relative risk ratio is that same as 1 - the [[relative risk reduction]].3 KB (393 words) - 23:44, 1 March 2009
- 207 bytes (30 words) - 10:32, 8 September 2009
- Auto-populated based on [[Special:WhatLinksHere/Relative risk ratio]]. Needs checking by a human.720 bytes (96 words) - 19:58, 11 January 2010
Page text matches
- #REDIRECT [[Relative risk ratio]]33 bytes (4 words) - 13:59, 5 January 2009
- Auto-populated based on [[Special:WhatLinksHere/Relative risk ratio]]. Needs checking by a human.720 bytes (96 words) - 19:58, 11 January 2010
- {{r|Relative risk ratio}}658 bytes (85 words) - 07:41, 8 January 2010
- In clinical [[epidemiology]] and [[evidence-based medicine]], the '''relative risk ratio''' or more simply the '''relative risk''', is a measure of the likelihood o Note that the relative risk ratio is that same as 1 - the [[relative risk reduction]].3 KB (393 words) - 23:44, 1 March 2009
- {{r|Relative risk ratio}}812 bytes (102 words) - 19:58, 11 January 2010
- {{r|Relative risk ratio}}1 KB (159 words) - 19:07, 11 January 2010
- {{r|Relative risk ratio}}1 KB (141 words) - 21:48, 19 May 2010
- Note that the relative risk reduction is that same as 1 - the [[relative risk ratio]].3 KB (389 words) - 23:44, 1 March 2009
- In a [[randomized controlled trial]], the [[relative risk ratio]] of fidaxomicin, as compared to [[vancomycin]], for recurrence of [[clostr2 KB (243 words) - 13:18, 2 February 2023
- The odds ratio is similar to the [[relative risk ratio]]. The two ratios will be numerically similar if the rates in the two group8 KB (1,193 words) - 16:04, 28 January 2011
- The [[relative risk ratio]] may be used to derive the number needed to treat:<ref name="pmid11914297" ...\frac{1}{CER * (1-RRR)} \mbox{, where CER is control event rate and RRR is relative risk ratio}</math>6 KB (844 words) - 10:50, 24 June 2009
- ...links&id=22340928 }} </ref> In a [[randomized controlled trial]], the [[relative risk ratio]] of [[dexamethasone]] ointment, as compared to [[placebo]], for nonhealing2 KB (267 words) - 22:23, 29 August 2013
- ...g/cite&retmode=ref&cmd=prlinks&id=18363896 }} </ref> In this study, the [[relative risk ratio]] of [[glucocorticosteroids for patients with severe hepatitis]] for mortal ...0.1002/14651858.CD007339.pub2 | pmc= | url= }} </ref> In this study, the [[relative risk ratio]] of [[pentoxifylline]] for mortality at various times was 0.6 and the [[re6 KB (825 words) - 13:57, 31 January 2012
- ...gent or elective [[percutaneous transluminal coronary angioplasty]], the [[relative risk ratio]] of [[cangrelor]] infusion compared to [[clopidogrel]] 600 mg or 300 mg or ...ndergoing urgent [[percutaneous transluminal coronary angioplasty]], the [[relative risk ratio]] of [[cangrelor infusion]] compared to 600 mg of [[clopidogrel]] prior to6 KB (873 words) - 12:25, 27 August 2013
- ...prlinks&id=22972059 }} </ref> In a [[randomized controlled trial]], the [[relative risk ratio]] of biannual [[alpha-fetoprotein]] and [[ultrasonography]], as compared to12 KB (1,601 words) - 08:30, 5 October 2012
- ! Intervention!!Number of [[randomized controlled trial|trial]]s||[[Relative risk ratio]] ...tudy!! change in pH in treatment group!!colspan="2"|Rates of recurrence||[[Relative risk ratio]]14 KB (1,798 words) - 12:23, 7 May 2009
- ...8625984"/><br/>([[odds ratio]])!!Cochrane<ref name="pmid19160228"/><br/>([[relative risk ratio]])15 KB (2,047 words) - 13:29, 10 February 2023
- ...trial]]<br/>46,551 patients for 13 years ||Colorectal cancer death:<br/>[[Relative risk ratio]] 0.67<br/>[[Relative risk reduction]] 33% || align="center"|305 ...ntrolled trial]]<br/>154,900 for 12 years ||Colorectal cancer death:<br/>[[Relative risk ratio]] 0.74 (sig)|| align="center"|102531 KB (4,194 words) - 13:28, 10 February 2023
- ...otein restriction<ref name="pmid17943769"/> || Diabetic renal disease || [[relative risk ratio|relative risk]] of end stage renal disease or death:<br/><center>0.23</cent ...n restriction<ref name="pmid16625550"/> || Non-diabetic renal disease || [[relative risk ratio|relative risk]] of renal death:<br/><center>0.69</center>27 KB (3,634 words) - 21:11, 5 October 2011
- ! !! Study type!![[Relative risk ratio]] or [[odds ratio]]<br/>for all-cause mortality ....elsevier.com/retrieve/pii/S0140-6736(08)61240-4 |issn=}}</ref> trials)||[[Relative risk ratio|RR]]=0.9231 KB (4,198 words) - 11:24, 23 July 2015
- ...n="2"| Comparison!!rowspan="2"| Outcome!!colspan="2"|Rates!! rowspan="2"|[[Relative risk ratio]]!!rowspan="2"|Comment24 KB (3,451 words) - 22:02, 5 April 2015
- ! !! Patients!!Intervention / duration!!Outcome!![[Relative risk ratio]]23 KB (3,173 words) - 08:48, 7 August 2014
- ...00 mg/day||Placebo|| venous thromboembolism at 37 months|| 4.8%|| 6.5%|| [[relative risk ratio]] = 0.74 (95% [[confidence interval|CI]]: 0.52 to 1.05; P=0.09)29 KB (3,995 words) - 11:45, 2 February 2023
- In a [[randomized controlled trial]], the [[relative risk ratio]] of [[fidaxomicin]], as compared to [[vancomycin]], for recurrence of C. d In a [[randomized controlled trial]], the [[relative risk ratio]] of [[fidaxomicin]], as compared to [[vancomycin]], for recurrence of C. d46 KB (6,252 words) - 17:10, 31 October 2013
- ...ized controlled trial]] of adults with community-acquired pneumonia, the [[relative risk ratio]] of [[prednisone]] 50 mg daily for 7 days, as compared to [[placebo]], red22 KB (2,899 words) - 14:57, 31 January 2015
- ...[[randomized controlled trial]]s of patients with mild hypertension, the [[relative risk ratio]] of [[pharmacotherapy]], as compared to [[placebo]], for mortality was 0.856 KB (7,418 words) - 15:13, 5 November 2013
- * Relative risk ratio55 KB (7,444 words) - 06:21, 29 August 2013
- * Relative risk ratio63 KB (8,790 words) - 06:57, 2 March 2021
- ! Intervention!! [[Relative risk ratio]]20 KB (2,755 words) - 01:35, 14 September 2013